Startup profile for Labster: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Labster funding, valuation and investors

Virtual laboratory simulations for STEM higher-education and corporate training.

Keep track of Labster

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series C

$60M · February 2021

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$60M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · Copenhagen, Denmark

Investors in latest funding

Lead: Andreessen Horowitz

Other: GGV Capital , Balderton Capital

Sources: latest funding Last verified: 2026-07-25

Overview

Labster provides virtual laboratory simulations where STEM students run experiments in immersive 3D environments when physical lab access is limited or costly. The platform serves higher-education institutions and corporate training programs with 300+ simulations across biology, chemistry, physics, and engineering. Andreessen Horowitz led a $60M Series C in February 2021 with GGV Capital, Balderton Capital, and Owl Ventures participating.

Why Labster is interesting

Labster democratizes lab access via 3D simulations — a16z led a $60M Series C in 2021 as COVID accelerated digital lab adoption in universities worldwide.

Product & use cases

Labster's 3D virtual labs let students conduct experiments with real scientific methodology — pipetting, microscopy, PCR, and more — in browser-based simulations with assessment and LMS integration.

  • University STEM lab courses when physical labs are full or unavailable
  • Pre-lab preparation before hands-on sessions
  • Corporate biotech and pharma training simulations
  • Remote and online degree program lab requirements

Key facts

  • Series C (Feb 2021): $60M led by a16z — PR Newswire
  • 300+ virtual lab simulations
  • Copenhagen-founded; global university customers

Funding history (newest first)

Investors in our directory

Funds linked from Labster's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: 300+ simulation catalog with pedagogical design and LMS integrations — depth competitors struggle to match.

Virtual labs supplement rather than replace physical labs. Labster benefited from COVID-driven adoption but must prove retention post-pandemic. International expansion (US, Europe) diversifies from Danish origins.

  • PraxiLabs direct

    Virtual lab simulations for MENA markets.

  • Visible Body adjacent

    Anatomy simulations; narrower scope.

  • Physical university labs incumbent

    Gold standard but capacity-limited and expensive.

Notable stories

  • Labster's $60M Series C in February 2021 came as universities worldwide sought digital lab alternatives during COVID-19 campus closures.
  • Founded in Copenhagen in 2011, Labster expanded to US universities before a16z led the growth round.

Industries

EdTech

Related funding articles

Venture Capital Tracker pieces that cover Labster's financing or category context.

FAQs about Labster

Practical answers founders, operators, and investors typically search for.

Virtual laboratory simulations for STEM education — 300+ experiments in 3D browser environments.
a16z (/fund/andreessen-horowitz) led $60M Series C; GGV (/fund/ggv-capital) and Balderton (/fund/balderton-capital) participated.
Supplements physical labs — useful when capacity, cost, or remote access limits hands-on time.
February 2021 — $60M.
Biology, chemistry, physics, engineering — see labster.com catalog.
Yes — integrates with Canvas, Blackboard, Moodle, etc.
Mads Bonde and Michael Bodekaer Jensen.
Yes — biotech and pharma employee training use cases.
Copenhagen, Denmark with global operations.
Not publicly disclosed.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.